Safety of d-ribose as a novel food pursuant to Regulation (EU) 2015/2283.

ABSTRACT: Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on D-ribose as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The applicant intends to market the NF as ingredient in a variety of foods, food supplements and in certain foods for specific groups. The NF is produced by fermentation using a transketolase-deficient strain of Bacillus subtilis and marketed as Bioenergy Ribose™. The information provided on the batch-to-batch variability, specifications, stability, production process and history of the organism used as a source of the NF is sufficient and does not raise safety concerns. The Panel considers that the effects observed in a subchronic toxicity study in rats could be th

SUBMITTER: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 

PROVIDER: S-EPMC7009719 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature